Finance
Blood transfusion software company's interest in Global Med purchased for $12 million
Published in Blood Weekly, January 26th, 2006
The transaction eliminates approximately $814 thousand in annual dividends and interest and reduces the company's total outstanding common shares from 27,815,419 to 22,955,224.
The company will receive $8 million from the investors for the purchase of zero coupon convertible preferred stock with detachable warrants and will use these proceeds to redeem or buy back the following securities and debt from GMIL: 3,500,000 of series AA preferred stock; 11,186,430 warrants...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-01-26)
More Articles from Blood Weekly
- Blood Safety
Prevalence of parvovirus B19 and hepatitis A virus determined in Portuguese blood donors - Complementary & Alternative Medicine
Effective alternative treatment to resurface major burns presented - Stem Cell Transplantation
Transplanted HSCs and BM stromal cells promote recovery in injured spinal cord - Transplant Medicine
New filter system is developed for umbilical cord blood banking for transplantation - Transplant Medicine
Unrelated donor-BMT can cure more than two-thirds of adult thalassemia patients - Acute Myeloid Leukemia
MRP3, BCRR and P-glycoprotein activities can prognosticate leukemia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
